Author details

Full Name

Peter J Wild

Affiliation

ORCID

Career Start Year

2000

Papers

284

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37562993	Proposal for a Novel Histological Scoring System as a Potential Grading Approach for Muscle-invasive Urothelial Bladder Cancer Correlating with Disease Aggressiveness and Patient Outcomes.	Eur Urol Oncol	2024
36597019	Evaluation of automatic discrimination between benign and malignant prostate tissue in the era of high precision digital pathology.		2023
36251795	Metachronous Osteosarcoma, A Differential Diagnosis to be Considered in Children With Osteosarcoma: A Review of Literature and a Case From Our Center.	Journal of Pediatric Hematology/Oncology	2023
36424731	Colonization with multidrug-resistant organisms is associated with impaired survival of patients with surgically resected cholangiocarcinoma.	Liver International	2023
37835839	Analytical Validation of an Immunohistochemical 7-Biomarker Prognostic Assay (immunoprint) for Early-Stage Cutaneous Melanoma in Archival Tissue of Patients with AJCC v8 T2-T3 Disease.		2023
37646786	Addendum: Sequencing of -alterations using NGS-based technology: annotation as a challenge.		2023
37989554	Impact of consensus molecular subtypes on survival with and without adjuvant chemotherapy in muscle-invasive urothelial bladder cancer.		2023
37894345	Deletions of and Detected by Copy-Number Variation Array Are Associated with Loss of p16 and MTAP Protein in Pleural Mesothelioma.		2023
37771441	Whole-exome sequencing of calcitonin-producing pancreatic neuroendocrine neoplasms indicates a unique molecular signature.		2023
37689579	Machine-Learning-Aided Prediction of Brain Metastases Development in Non-Small-Cell Lung Cancers.		2023
37686598	Active Autophagy Is Associated with Favorable Outcome in Patients with Surgically Resected Cholangiocarcinoma.		2023
36590323	Metabolic reprogramming of hepatocytes by eggs.		2023
36831256	Overexpression of KMT9Î± Is Associated with Aggressive Basal-like Muscle-Invasive Bladder Cancer.		2023
37273239	Pathogenetic mechanisms and therapeutic approaches of acute-to-chronic liver failure.		2023
37270477	Optimizing identification of consensus molecular subtypes in muscle-invasive bladder cancer: a comparison of two sequencing methods and gene sets using FFPE specimens.		2023
37268876	Radiomics for therapy-specific head and neck squamous cell carcinoma survival prognostication (part I).		2023
37016761	Fluorescence confocal microscopy on liver specimens for full digitization of transplant pathology.		2023
36757619	Impact of IDH1 mutation on clinical course of patients with intrahepatic cholangiocarcinoma: a retrospective analysis from a German tertiary center.		2023
36631548	CT-radiomics and clinical risk scores for response and overall survival prognostication in TACE HCC patients.		2023
37443286	Transglutaminase 2 is associated with adverse colorectal cancer survival and represents a therapeutic target.		2023
36804153	Computed Tomography Radiomics to Differentiate Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma.		2023
36621159	The NeuroSAFE frozen section technique during radical prostatectomy - Implementation and optimization of technical aspects in a routine pathology workflow.		2023
37370864	A Comparison of Two Different FFPE Tissue Dissection Methods for Routine Diagnostics in Molecular Pathology: Manual Macrodissection versus Automated Microdissection Using the Roche "AVENIO Millisect" System.		2023
37175005	External Tertiary-Care-Hospital Validation of the Epidemiological SEER-Based Nomogram Predicting Downgrading in High-Risk Prostate Cancer Patients Treated with Radical Prostatectomy.	Diagnostics (Basel)	2023
36793050	Tumor-associated macrophages and Tregs influence and represent immune cell infiltration of muscle-invasive bladder cancer and predict prognosis.		2023
37489084	Colorectal Cancer Organoid-Stroma Biobank Allows Subtype-Specific Assessment of Individualized Therapy Responses.	Cancer Discov	2023
36975480	CXCL1 and CXCL6 Are Potential Predictors for HCC Response to TACE.		2023
35093044	The routine use of LCD-Array hybridisation technique for HPV subtyping in the diagnosis of penile carcinoma compared to other methods.	BMC Urology	2022
36106328	How to learn with intentional mistakes: NoisyEnsembles to overcome poor tissue quality for deep learning in computational pathology.	Frontiers in Medicine	2022
35969265	[Predictive molecular diagnostics in breast cancer : What are the requirements for pathology today and in the future?]		2022
35710851	The significance of the extent of tissue embedding for the detection of incidental prostate carcinoma on transurethral prostate resection material: the more, the better?	Virchows Archiv	2022
36230626	Expression of MUC16/CA125 Is Associated with Impaired Survival in Patients with Surgically Resected Cholangiocarcinoma.	Cancers	2022
35492239	Single-cell proteomics defines the cellular heterogeneity of localized prostate cancer.	Cell Rep Med	2022
36137398	Impact of small duct- and large duct type on survival in patients with intrahepatic cholangiocarcinoma: Results from a German tertiary center.	Pathology Research and Practice	2022
36270195	Dual-energy CT based material decomposition to differentiate intrahepatic cholangiocarcinoma from hepatocellular carcinoma.	European Journal of Radiology	2022
36128324	Site of analysis matters - Ongoing complete response to Nivolumab in a patient with HIV/HPV related metastatic anal cancer and mutation.	Oncotarget	2022
35477343	Use of MS-GUIDE for identification of protein biomarkers for risk stratification of patients with prostate cancer.	Clin Proteomics	2022
35407665	Impact of Liver Fibrosis on Survival of Patients with Intrahepatic Cholangiocarcinoma Receiving Gemcitabine-Based Chemotherapy.	Journal of Clinical Medicine	2022
35402268	Neoadjuvant Chemoradiotherapy for Oral Cavity Cancer: Predictive Factors for Response and Interim Analysis of the Prospective INVERT-Trial.	Frontiers in Oncology	2022
35718092	Comprehensive Validation of Diagnostic Next-Generation Sequencing Panels for Acute Myeloid Leukemia Patients.	J Mol Diagn	2022
36564761	Increased HRD score in cisplatin resistant penile cancer cells.		2022
34331570	Novel RGAG1-BCOR gene fusion revealed in a somatic soft tissue sarcoma with a long follow-up.	Virchows Arch	2022
35321552	Development and validation of a cell cycle progression signature for decentralized testing of men with prostate cancer.	Biomarkers in Medicine	2022
35251494	Sequencing of -alterations using NGS-based technology: annotation as a challenge.	Oncotarget	2022
34449004	The peri- and intratumoral immune cell infiltrate and PD-L1 status in invasive squamous cell carcinomas of the penis.		2022
35245447	The proteogenomic subtypes of acute myeloid leukemia.	Cancer Cell	2022
35024940	Tumor-associated immune cell infiltrate density in penile squamous cell carcinomas.	Virchows Archiv	2022
35119111	Deep learning based on hematoxylin-eosin staining outperforms immunohistochemistry in predicting molecular subtypes of gastric adenocarcinoma.	Journal of Pathology	2022
30905598	Implementation of Intraoperative Frozen Section During Radical Prostatectomy: Short-term Results from a German Tertiary-care Center.	Eur Urol Focus	2021
34063557	Correlation of MRI-Lesion Targeted Biopsy vs. Systematic Biopsy Gleason Score with Final Pathological Gleason Score after Radical Prostatectomy.	Diagnostics (Basel)	2021